Twist Bioscience Publishes Preclinical Data Validating GLP-1R Antagonist Antibody for Congenital Hyperinsulinism Treatment.

-Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

June 27, 2023 | Tuesday | News
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics

Merger approved with large majority by the shareholders of both companies New governance structure implemented Ambition to create a global leader in ex...

June 27, 2023 | Tuesday | News
Challenges and strategies for characterization of next-generation bispecific antibodies

But developing a bispecific antibody presents several challenges, including those related to dual binding, screening, pharmacodynamics, tissue tropism, and...

June 22, 2023 | Thursday | Analysis
FBI Approves QIAGEN's ForenSeq MainstAY Workflow for U.S. DNA Index System

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that the U.S. Federal Bureau of Investigation (FBI) has approved its ForenSeq® Mains...

June 22, 2023 | Thursday | News
Next-gen Cologuard test raises non-invasive screening bar with 94% sensitivity for colorectal cancer at 91% specificity.

BLUE-C study met all endpoints, showing improved cancer sensitivity, specificity, and precancer sensitivity 20,000-participant study reflects racial ...

June 21, 2023 | Wednesday | News
Illumina Ventures to Launch Illumina® Ventures Labs

“This expansion of our relationship with Illumina is a continuation of Illumina Ventures’ strategy to pursue earlier stage investing,” sa...

June 21, 2023 | Wednesday | News
Abu Dhabi, M42, AbbVie Partner to Advance Personalized Medicine & Genomics

The MoU was signed by Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Center at the Department of Health – Abu Dhabi(DoH), Fra...

June 20, 2023 | Tuesday | News
TG ImmunoPharma Announces FDA Clearance for Clinical Trial of TGI-6 Bispecific Antibody

TG ImmunoPharma Co., Ltd. (TGI), a leading biotech company focused on the development of novel immuno-oncology therapies, is pleased to announce that the F...

June 17, 2023 | Saturday | News
Promising Results in Early-Stage Study of Hodgkin Lymphoma with Tessa Therapeutics' 'Off-the-Shelf' CAR-T Therapy

Safety data encouraging with no graft-versus-host-disease and no neurotoxicity Updated data highlighted in podium presentation at the 17th International...

June 16, 2023 | Friday | News
Astellas and Cullgen Forge Strategic Collaboration to Advance Targeted Protein Degraders

Under the terms of the agreement, the two companies aim to develop multiple targeted protein degraders by combining Cullgen's proprietary uSMITE™ tar...

June 15, 2023 | Thursday | News
Future Fields and Jenthera Therapeutics Collaborate on Novel Cancer Biologics Delivery Protein

Future Fields, a pioneering biotechnology company that has built the world’s first synthetic biology system to use fruit flies for recombinant protei...

June 14, 2023 | Wednesday | News
Danish National Genome Center Chooses QIAGEN for Oncology Genome Sequencing Variant Interpretation

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its variant interpretation and reporting software, QIAGEN Clinical Insight (QCI) In...

June 14, 2023 | Wednesday | News
Increased Demand for ABA Therapy Requires Precision Treatment Planning to Achieve Timely Access to Care

According to a recent report by the Centers for Disease Control and Prevention (CDC), 1 in 36 children in the U.S. is diagnosed with an autism spectrum dis...

June 13, 2023 | Tuesday | News
Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced an agreement with The University of Texas MD And...

June 13, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close